# Monitoring anti-PD-1-based immunotherapy in non-small cell lung cancer with FDG PET: introduction of iPERCIST

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/monitoring-anti-pd-1-based-immunotherapy-in-non-small-cell-lung-cancer-with-fdg/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Lucas Goldfarb,Boris Duchemann,Kader Chouahnia,Laurent Zelek,Michaël Soussan |
| Citations | 186 |
| DOI | 10.1186/s13550-019-0473-1 |
| Fields | Medicine |
| Open Access | true |
| OA Status | gold |
| OA URL | https://ejnmmires.springeropen.com/track/pdf/10.1186/s13550-019-0473-1 |
| OpenAlex ID | https://openalex.org/W2915937749 |
| PMID | 30694399 |
| Type | article |
| Year | 2019 |

## Paper authors

- [Boris Duchemann](https://scholariq.org/researchers/boris-duchemann/)

## Paper primary topic

- [Cancer Immunotherapy and Biomarkers](https://scholariq.org/topics/cancer-immunotherapy-and-biomarkers/)

## Paper topics

- [Cancer Immunotherapy and Biomarkers](https://scholariq.org/topics/cancer-immunotherapy-and-biomarkers/)
- [Ferroptosis and cancer prognosis](https://scholariq.org/topics/ferroptosis-and-cancer-prognosis/)
- [Inflammatory Biomarkers in Disease Prognosis](https://scholariq.org/topics/inflammatory-biomarkers-in-disease-prognosis/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.